Guidelines for vitamin supplements in chronic kidney disease patients: What is the evidence?

Journal of Renal Nutrition

Volumn 21, Issue 1, 2011, Pages 117-119

  Handelman, Garry J ^a   Levin, Nathan W ^b  

^a UNIVERSITY OF MASSACHUSETTS LOWELL   (United States)

^b RENAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN;

CHRONIC KIDNEY FAILURE; DIET SUPPLEMENTATION; HEALTH CARE POLICY; HUMAN; MALNUTRITION; METABOLISM; REVIEW;

DIETARY SUPPLEMENTS; HUMANS; KIDNEY FAILURE, CHRONIC; MALNUTRITION; NUTRITION POLICY; VITAMINS;

EID: 78650716126     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2010.11.004     Document Type: Review

References (15)

1. Sullivan J.F., Eisenstein A.B. Ascorbic acid depletion in patients undergoing chronic hemodialysis. Am J Clin Nutr 1970, 23:1339-1346.
2. Shemin D., Bostom A.G., Selhub J. Treatment of hyperhomocysteinemia in end-stage renal disease. Am J Kidney Dis 2001, 38(4 Suppl 1):S91-S94.
3. Fissell R.B., Bragg-Gresham J.L., Gillespie B.W., et al. International variation in vitamin prescription and association with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 2004, 44:293-299.
4. Rimm E.B., Stampfer M.J., Ascherio A., et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993, 328:1450-1456.
5. Stampfer M.J., Hennekens C.H., Manson J.E., et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993, 328:1444-1449.
6. Boaz M., Smetana S., Weinstein T., et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 2000, 356:1213-1218.
7. Attallah N., Osman-Malik Y., Frinak S., et al. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia. Am J Kidney Dis 2006, 47:644-654.
8. Deved V., Poyah P., James M.T., et al. Ascorbic acid for anemia management in hemodialysis patients: a systematic review and meta-analysis. Am J Kidney Dis 2009, 54:1089-1097.
9. Thornalley P.J., Babaei-Jadidi R., Al Ali H., et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 2007, 50:2164-2170.
10. Stein G., Schone S., Sperschneider H., et al. Vitamin status in patients with chronic renal failure. Contrib Nephrol 1988, 65:33-42.
11. Barbara P.G., Manuel B., Elisabetta M., et al. The suddenly speechless florist on chronic dialysis: the unexpected threats of a flower shop? Diagnosis: dialysis related Wernicke encephalopathy. Nephrol Dial Transplant 2006, 21:223-225.
12. Ihara M., Ito T., Yanagihara C., et al. Wernicke's encephalopathy associated with hemodialysis: report of two cases and review of the literature. Clin Neurol Neurosurg 1999, 101:118-121.
13. Wang A.Y., Sea M.M., Ip R., et al. Independent effects of residual renal function and dialysis adequacy on dietary micronutrient intakes in patients receiving continuous ambulatory peritoneal dialysis. Am J Clin Nutr 2002, 76:569-576.
14. Cruz D.N., De Cal M., Garzotto F., et al. Effect of vitamin E-coated dialysis membranes on anemia in patients with chronic kidney disease: an Italian multicenter study. Int J Artif Organs 2008, 31:545-552.
15. Rice L., Alfrey C.P., Driscoll T., et al. Neocytolysis contributes to the anemia of renal disease. Am J Kidney Dis 1999, 33:59-62.